Publication | Open Access
Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway
53
Citations
72
References
2024
Year
Cancer ImmunosurveillanceCar-t CellsMedicineImmunologyPharmacologyAntitumor EfficacyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentWnt PathwayOncologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1